Elevated WBC in SLE: Causes and Clinical Approach
In SLE patients, an elevated WBC count is uncommon and should immediately trigger evaluation for infection or glucocorticoid therapy as the primary causes, rather than lupus disease activity itself. 1
Primary Causes to Consider
Infection (Most Important)
- Infection is the leading cause of elevated WBC in SLE patients and represents a critical diagnostic priority given that infections are among the leading causes of morbidity and mortality in this population. 2, 3
- CRP elevation above 50 mg/L strongly suggests superimposed infection rather than SLE disease activity alone, as most SLE patients rarely have elevated CRP during disease flares. 1
- The frequency of infections is increased due to both immunosuppressive therapy and immune disturbances inherent to lupus itself. 3
- Specific infections to screen for include:
- Tuberculosis (2.5-13.8% in endemic areas, 0-1.4% in non-endemic areas) - test before starting glucocorticoids and immunosuppressants. 2
- CMV antigenaemia (18-44% of patients, particularly with pulse methylprednisolone and cyclophosphamide) - consider testing in patients on high-dose glucocorticoids. 2
- HIV, HBV, and HCV - screen before administering immunosuppressive therapy. 2
Glucocorticoid Therapy
- High-dose glucocorticoids commonly cause leukocytosis (granulocytosis) and may occur during acute exacerbations of SLE when steroids are escalated. 4
- This iatrogenic leukocytosis can complicate the clinical picture and must be distinguished from infection-related elevations. 4
Immunosuppressive Medication Effects
- Mycophenolate mofetil paradoxically increases WBC count in patients with baseline leukopenia (WBC <3000/mm³), with counts rising from 2.57 to 5.13 (P=0.0047). 5
- However, mycophenolate mofetil also increases the rate of bacterial infections (4% vs 9%, P=0.0036), so elevated WBC may reflect concurrent infection. 5
Critical Diagnostic Algorithm
Step 1: Assess for Infection
- Check CRP level - values >50 mg/L are red flags for infection rather than lupus activity. 1
- Obtain cultures and imaging as clinically indicated based on symptoms.
- Consider CMV testing if patient is on high-dose glucocorticoids or pulse immunosuppression. 2
Step 2: Review Medication History
- Document current glucocorticoid dose - doses >20 mg/day commonly cause leukocytosis. 2, 4
- Note recent changes in immunosuppressive therapy, particularly mycophenolate mofetil initiation. 5
Step 3: Assess Infection Risk Factors
- Severe lymphopenia (<500 cells/mm³) and severe neutropenia (<500 cells/mm³) increase infection risk. 1
- Low IgG3 (≤60 μg/ml) or IgG4 (≤20 μg/ml) levels are associated with increased infection risk. 2
- Lymphocyte counts ≤1×10⁹/L increase infection susceptibility. 2
Important Clinical Pitfalls
Do not assume elevated WBC represents lupus disease activity - this is atypical, as leukopenia (not leukocytosis) is the characteristic hematological pattern in active SLE. 1, 6
Infection and lupus flare can coexist, making diagnosis challenging and requiring careful evaluation of both possibilities simultaneously. 3
Drug-induced changes must always be considered when evaluating any WBC abnormality in SLE patients on immunosuppressive therapy. 1, 4